What is the recommended ceftriaxone dose in milligrams per kilogram of body weight for pediatric patients, including dosing for neonates and severe infections such as meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftriaxone Dosage per Kilogram

For most pediatric infections, ceftriaxone is dosed at 50-75 mg/kg/day, while bacterial meningitis requires 100 mg/kg/day (maximum 4 grams daily), administered either once daily or divided every 12 hours.

Standard Pediatric Dosing by Indication

General Infections (Non-Meningitis)

  • Skin/soft tissue infections: 50-75 mg/kg once daily or divided every 12 hours 1
  • Pneumonia: 50-100 mg/kg/day every 12-24 hours 1, 2
  • Sepsis (older children): 50 mg/kg daily 3
  • Intra-abdominal infections: 50-75 mg/kg/day every 12-24 hours 4
  • Maximum daily dose: 2 grams for non-meningitis infections 5

Severe Infections Requiring Higher Doses

  • Meningitis: 100 mg/kg/day (maximum 4 grams daily) 6, 7
    • Can be given as 50 mg/kg every 12 hours OR 100 mg/kg once daily 3
    • Recent evidence suggests once-daily dosing achieves better CSF penetration earlier 8
  • Typhoid fever: 80 mg/kg daily 3
  • Dysentery (second-line): 50-80 mg/kg daily 3

Single-Dose Indications

  • Acute otitis media: 50 mg/kg IM single dose (maximum 1 gram) 5
  • Uncomplicated gonorrhea: 250 mg IM single dose (adults) 5

Neonatal Dosing (≤28 Days)

Critical caveat: Ceftriaxone is contraindicated in premature neonates and in any neonate requiring calcium-containing IV solutions due to precipitation risk 5.

For neonates who can receive ceftriaxone:

  • Age ≤7 days: 50 mg/kg/day every 24 hours 9, 6
  • Age >7 days and ≤2000g: 50 mg/kg/day every 24 hours 9, 6
  • Age >7 days and >2000g: 50-75 mg/kg/day every 24 hours 9, 6
  • Infant sepsis/meningitis: 50 mg/kg daily (can increase to 100 mg/kg for meningitis after initial dose) 3, 6

Administer IV doses over 60 minutes in neonates to reduce bilirubin encephalopathy risk 5.

Dosing Frequency: Once vs. Twice Daily

The evidence supports both regimens are effective, but with nuances:

  • Once-daily dosing (100 mg/kg) achieves higher peak CSF concentrations and reaches therapeutic targets faster in meningitis 8, 10
  • Twice-daily dosing (50 mg/kg every 12 hours) maintains more consistent CSF levels throughout the dosing interval 8
  • For empirical meningitis treatment, 100 mg/kg once daily is preferred based on pharmacokinetic modeling showing 88% probability of target attainment at 24 hours versus 53% for divided dosing 8

Administration Guidelines

Intravenous

  • Standard infusion time: 30 minutes for children and adults 5
  • Neonates: Infuse over 60 minutes 5
  • Concentration: 10-40 mg/mL (lower concentrations acceptable) 5

Intramuscular

  • Concentration: 250 mg/mL or 350 mg/mL 5
  • Inject into large muscle mass with aspiration to avoid vascular injection 5

Important Clinical Caveats

Calcium Interactions

  • Never mix with calcium-containing solutions (Ringer's, Hartmann's, parenteral nutrition) 5
  • In non-neonates, can give sequentially if lines flushed thoroughly between infusions 5
  • No interaction with oral calcium products 5

Renal/Hepatic Impairment

  • No dose adjustment needed for renal or hepatic dysfunction up to 2 grams daily in adults 5
  • Pediatric patients with severe renal impairment may require monitoring but typically no adjustment 6

Maximum Doses

  • Non-meningitis: 2 grams/day 5
  • Meningitis: 4 grams/day 5
  • Surgical prophylaxis: 1 gram single dose 5

Duration of Therapy

  • Meningitis: 7-14 days (or up to 21 days for neonatal meningitis) 3, 6
  • Most infections: Continue at least 2 days after symptom resolution, typically 4-14 days 5
  • Streptococcus pyogenes: Minimum 10 days 5

Pathogen-Specific Considerations

The dosing recommendations above cover common pathogens (S. pneumoniae, H. influenzae, N. meningitidis) with MICs ≤1-4 mg/L. For S. aureus meningitis (MIC 4 mg/L), neither standard regimen achieves adequate CSF concentrations—vancomycin or alternative therapy is required 8.

References

Guideline

practice guidelines for the management of bacterial meningitis.

Clinical Infectious Diseases, 2004

Related Questions

What is the appropriate ceftriaxone dosage for pediatric patients, including neonates (≤28 days) and infants (>28 days), and are there any dose adjustments for conditions such as meningitis, severe sepsis, hepatic impairment, or hyperbilirubinemia?
What is the recommended ceftriaxone dose for a 4‑month‑old infant?
What is the recommended meningitis (meningeal) dose of ceftriaxone for adults and children?
What is the appropriate ceftriaxone dose for a patient weighing 33 kg?
What cefdinir dose in pill form should be given to a child weighing 24.9 kg?
What is the appropriate treatment for a patient with total cholesterol of 247 mg/dL and serum glutamic‑pyruvic transaminase (SGPT/ALT) of 52 U/L?
In a patient with a total cholesterol of 247 mg/dL and a mildly elevated alanine aminotransferase (ALT) of 52 U/L, what are the indications for initiating statin therapy?
A patient with atrial fibrillation status post left atrial appendage closure (Watchman) who now has recurrent atrial flutter and ongoing atrial fibrillation episodes after cardioversion—should he continue anticoagulation?
What is the recommended diagnostic work‑up and management for a patient with hepatosplenomegaly, cholelithiasis, hepatitis C infection, and right flank pain?
For an asymptomatic adult aged ≥40 years without known atherosclerotic disease, how should I interpret and manage different coronary artery calcium (CAC) scores?
What analgesic regimen should be prescribed for a patient with mild‑to‑moderate hepatitis C and flank pain, considering the liver disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.